Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Adma Biologics (ADMA) Receivables - Other (2016 - 2018)

Adma Biologics (ADMA) has disclosed Receivables - Other for 3 consecutive years, with $961145.0 as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Receivables - Other fell 22.84% year-over-year to $961145.0, compared with a TTM value of $961145.0 through Dec 2018, down 22.84%, and an annual FY2018 reading of $961145.0, down 22.84% over the prior year.
  • Receivables - Other was $961145.0 for Q4 2018 at Adma Biologics, down from $1.0 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $1.2 million in Q4 2017 and bottomed at $726409.0 in Q1 2018.
  • Average Receivables - Other over 3 years is $1.0 million, with a median of $987823.0 recorded in 2016.
  • The sharpest move saw Receivables - Other increased 28.46% in 2017, then dropped 22.84% in 2018.
  • Year by year, Receivables - Other stood at $969675.0 in 2016, then rose by 28.46% to $1.2 million in 2017, then decreased by 22.84% to $961145.0 in 2018.
  • Business Quant data shows Receivables - Other for ADMA at $961145.0 in Q4 2018, $1.0 million in Q3 2018, and $1.0 million in Q2 2018.